Neoadjuvant Pembrolizumab Plus Chemotherapy in Early-Stage Triple-Negative Breast Cancer: A Nationwide Retrospective Turkish Oncology Group Study - Karci, Ebru; Bilici, Ahmet; Bayram, Buket; Celayir, Melisa; Ozyurt, Neslihan; Uluc, Basak Oyan; Eken, Aynur; Basaran, Gul; Demirci, Umut; Kemal, Yasemin; Oruncu, Mehmet Berk; Olmez, Omer Fatih; et al. (MDPI, 2024)
Keywords: triple\\-negative breast cancer; neoadjuvant therapy; pembrolizumab; pathological complete response; real world; event\\-free survival; overall survival; safety